• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化硅涂层塑料注射瓶的性能稳定性

Performance Stability of Silicone Oxide-Coated Plastic Parenteral Vials.

作者信息

Weikart Christopher M, Pantano Carlo G, Shallenberger Jeff R

机构信息

SiO2 Medical Products Inc., Auburn, AL; and

The Pennsylvania State University, The Department of Materials Science and Engineering, University Park, PA.

出版信息

PDA J Pharm Sci Technol. 2017 Jul-Aug;71(4):317-327. doi: 10.5731/pdajpst.2016.007278. Epub 2017 Apr 17.

DOI:10.5731/pdajpst.2016.007278
PMID:28416645
Abstract

A new packaging system was developed for parenteral pharmaceuticals that combines the best attributes of plastic and glass without their respective drawbacks. This technological advancement is based on the synergy between high-precision injection-molded plastics and plasma coating technology. The result is a shatter-resistant, optically clear, low-particulate, and chemically durable packaging system. The demand for this product is driven by the expanding market, regulatory constraints, and product recalls for injectable drugs and biologics packaged in traditional glass materials. It is shown that this new packaging system meets or exceeds the important performance characteristics of glass, especially in eliminating the glass delamination and breakage that has been observed in many products. The new packaging system is an engineered, multilayer, glass-coated plastic composite that provides a chemically stable contact surface and oxygen barrier performance that exceeds a 2 year shelf life requirement. Evaluation of the coating system characteristics and performance stability to chemical, temperature, and mechanical extremes are reported herein. A new packaging system for parenteral pharmaceuticals was developed that combines the best attributes of plastic and glass without their respective drawbacks. This technological advancement is based on the synergy between high-precision injection-molded plastics and plasma coating technology. The result is a shatter-resistant, optically clear, low-particulate, and chemically durable packaging system. It is shown that this new packaging system meets or exceeds the important performance characteristics of glass, especially in eliminating the glass delamination and breakage that has been observed in many products. The new packaging system is an engineered, multilayer, glass-coated plastic composite that provides a chemically stable contact surface and oxygen barrier performance that exceeds a 2 year shelf life requirement. Evaluation of the coating system characteristics and performance stability to chemical, temperature, and mechanical extremes are reported herein.

摘要

一种用于肠胃外药物的新型包装系统被开发出来,它结合了塑料和玻璃的最佳特性,同时又没有它们各自的缺点。这一技术进步基于高精度注塑塑料和等离子体涂层技术之间的协同作用。其结果是一种抗破碎、光学透明、低颗粒且化学耐用的包装系统。对这种产品的需求受到不断扩大的市场、监管限制以及用传统玻璃材料包装的注射用药物和生物制品的产品召回等因素的推动。结果表明,这种新型包装系统达到或超过了玻璃的重要性能特征,尤其是在消除许多产品中观察到的玻璃分层和破碎方面。这种新型包装系统是一种经过精心设计的多层玻璃涂层塑料复合材料,它提供了一个化学稳定的接触表面和超过两年保质期要求的氧气阻隔性能。本文报道了对涂层系统特性以及其在化学、温度和机械极端条件下的性能稳定性的评估。一种用于肠胃外药物的新型包装系统被开发出来它结合了塑料和玻璃的最佳特性,同时又没有它们各自的缺点。这一技术进步基于高精度注塑塑料和等离子体涂层技术之间的协同作用。其结果是一种抗破碎、光学透明、低颗粒且化学耐用的包装系统。结果表明,这种新型包装系统达到或超过了玻璃的重要性能特征,尤其是在消除许多产品中观察到的玻璃分层和破碎方面。这种新型包装系统是一种经过精心设计的多层玻璃涂层塑料复合材料,它提供了一个化学稳定的接触表面和超过两年保质期要求的氧气阻隔性能。本文报道了对涂层系统特性以及其在化学、温度和机械极端条件下的性能稳定性的评估。

相似文献

1
Performance Stability of Silicone Oxide-Coated Plastic Parenteral Vials.氧化硅涂层塑料注射瓶的性能稳定性
PDA J Pharm Sci Technol. 2017 Jul-Aug;71(4):317-327. doi: 10.5731/pdajpst.2016.007278. Epub 2017 Apr 17.
2
Inhibiting Sterilization-Induced Oxidation of Large Molecule Therapeutics Packaged in Plastic Parenteral Vials.抑制塑料安瓿包装的大分子治疗药物的灭菌诱导氧化
PDA J Pharm Sci Technol. 2018 Jan-Feb;72(1):35-43. doi: 10.5731/pdajpst.2017.008011. Epub 2017 Sep 19.
3
Novel Mechanism of Glass Delamination in Type 1A Borosilicate Vials Containing Frozen Protein Formulations.含冷冻蛋白质制剂的1A型硼硅玻璃小瓶中玻璃分层的新机制
PDA J Pharm Sci Technol. 2013 Jul-Aug;67(4):323-35. doi: 10.5731/pdajpst.2013.00925.
4
Introducing the Alba® Primary Packaging Platform. Part 2: Inorganic Extractables Evaluation.介绍阿尔巴®初级包装平台。第2部分:无机可提取物评估。
PDA J Pharm Sci Technol. 2019 May-Jun;73(3):235-246. doi: 10.5731/pdajpst.2018.009423. Epub 2019 Jan 16.
5
Complexing Agents and pH Influence on Chemical Durability of Type I Molded Glass Containers.络合剂和pH值对I型模制玻璃容器化学耐久性的影响
PDA J Pharm Sci Technol. 2017 Jul-Aug;71(4):306-316. doi: 10.5731/pdajpst.2016.006304.
6
A new glass option for parenteral packaging.一种用于肠胃外给药包装的新型玻璃选择。
PDA J Pharm Sci Technol. 2014 Sep-Oct;68(5):527-34. doi: 10.5731/pdajpst.2014.00998.
7
Aluminum and Phthalates in Calcium Gluconate: Contribution From Glass and Plastic Packaging.葡萄糖酸钙中的铝和邻苯二甲酸盐:玻璃和塑料包装的影响
J Pediatr Gastroenterol Nutr. 2017 Jan;64(1):109-114. doi: 10.1097/MPG.0000000000001243.
8
A Case Study Demonstrating the Importance of Glass Vial Selection for Parenteral Pharmaceutical Products.一个案例研究,展示了玻璃小瓶选择对于注射用药物产品的重要性。
J Pharm Sci. 2024 Sep;113(9):2974-2980. doi: 10.1016/j.xphs.2024.06.008. Epub 2024 Jun 15.
9
Filtration of Glass Delamination Particles with West Pharmaceutical Vial Adapters.使用西氏制药瓶适配器过滤玻璃分层颗粒。
PDA J Pharm Sci Technol. 2015 Nov-Dec;69(6):669-76. doi: 10.5731/pdajpst.2015.01076.
10
Comparative Leachable Study of Glass Vials to Demonstrate the Impact of Low Fill Volume.玻璃小瓶的对比可浸出物研究,以证明低灌装量的影响。
PDA J Pharm Sci Technol. 2019 Jul-Aug;73(4):345-355. doi: 10.5731/pdajpst.2018.009472. Epub 2019 Feb 15.

引用本文的文献

1
A comparative study of freeze-drying heat transfer in polymeric vials and glass vials.聚合物小瓶和玻璃小瓶冻干传热的比较研究。
Sci Rep. 2023 Oct 23;13(1):18092. doi: 10.1038/s41598-023-40777-3.
2
Hybrid Blood Collection Tubes: Combining the Best Attributes of Glass and Plastic for Safety and Shelf life.混合采血试管:结合玻璃和塑料的最佳特性以确保安全性和延长保质期。
SLAS Technol. 2020 Oct;25(5):484-493. doi: 10.1177/2472630320915842. Epub 2020 May 19.
3
Subvisible Particles in IVIg Formulations Activate Complement in Human Serum.
静脉注射用免疫球蛋白制剂中的亚可见颗粒会在人血清中激活补体。
J Pharm Sci. 2020 Jan;109(1):558-565. doi: 10.1016/j.xphs.2019.10.041. Epub 2019 Oct 28.